Guangzhou Wondfo Biotech Co.,Ltd.’s Net Profit Rose 491.5% in First Quarter of 2022

Guangzhou Wondfo Biotech Co.,Ltd. (广州万孚生物技术股份有限公司) (300482.SZ) reported a net profit of 901.7 million yuan in the first quarter of 2022, up 491.5% year-on-year.

Meanwhile, the company posted 2.6 billion yuan in revenue, up 276.9% year-on-year.

At the end of the reporting period, it had 6.6 billion yuan in total assets and 2.2 billion yuan in total liabilities, with a liability-to-asset ratio of 33.5%.